Back to Search Start Over

In vitro bioactivity, mechanical, and cell interaction of sodium chloride-added calcium sulfate-hydroxyapatite composite bone cements.

Authors :
Jaita P
Randorn C
Watcharapasorn A
Jarupoom P
Source :
RSC advances [RSC Adv] 2024 Nov 06; Vol. 14 (48), pp. 35460-35474. Date of Electronic Publication: 2024 Nov 06 (Print Publication: 2024).
Publication Year :
2024

Abstract

In this research, sodium chloride-added calcium sulfate-hydroxyapatite composite bone cements (0.70CaS-0.30HAP)/ x NaCl were studied. Different wt% of NaCl (0, 1.5, and 2.5) were added to 0.70CaS-0.30HAP bone cement to investigate the setting time, injectability, washout resistance, phase evolution, physical properties, water absorption, microstructural, chemical analysis, mechanical strength, statistical analysis, in vitro apatite-forming ability, and in vitro cytotoxicity. With increasing NaCl, the initial setting time decreased to around 3.18 min. X-ray pattern revealed that all composite bone cement samples had mixed phases of CaS, HAP, brushite, gypsum, and NaCl. Water absorption and average grain size increased with increasing NaCl content. The densification and mechanical performances, including σ <subscript>c</subscript> , σ <subscript>f</subscript> , and E values, slightly decreased with increasing NaCl content, correlated with the increasing porosity value. This resulted in the production of a porous structure, which caused an excellent in vitro apatite-forming ability. The x = 2.5 sample showed good bioactivity, inducing the highest apatite mineralization ability in the SBF solution. Additionally, in vitro cell culture analysis showed above 94.12% cell viability against a high concentration (@ 200 μg mL <superscript>-1</superscript> ) for the x = 2.5 sample, revealing cytocompatibility. The obtained results indicated that the (0.70CaS-0.30HAP)/2.5NaCl composite bone cement, with good injectability, bioactivity, and cytocompatibility, are promising candidates for biomedical applications.<br />Competing Interests: The authors declare no conflict of interest.<br /> (This journal is © The Royal Society of Chemistry.)

Details

Language :
English
ISSN :
2046-2069
Volume :
14
Issue :
48
Database :
MEDLINE
Journal :
RSC advances
Publication Type :
Academic Journal
Accession number :
39507684
Full Text :
https://doi.org/10.1039/d4ra06034b